TCM
JNCE

Tang Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Tang Capital Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,300,087
Closed -$9.81M – 122
2023
Q1 		$9.81M Buy
+5,300,087
New +$9.81M 1.46% 24